ARTICLE | Finance

In the clover

VCs in cancer play Clovis look to go public after just over two years

June 27, 2011 7:00 AM UTC

VCs have put $75.5 million into Clovis Oncology Inc. - a little more than half of the $145 million series A round originally committed after the company was formed in April 2009. Now the cancer play is looking to raise up to $149.5 million in an IPO on NASDAQ.

The original bet was on the management team, which came from Pharmion Corp. after it sold to Celgene Corp. (NASDAQ:CELG) for $2.9 billion in 2008. In November 2009, Clovis in-licensed what is now its lead candidate from Clavis Pharma ASA (OSE:CLAVIS)...